Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. / Nøstvik, Miriam; Kateta, Sarah M.; Schönewolf-Greulich, Bitten; Afenjar, Alexandra; Barth, Magalie; Boschann, Felix; Doummar, Diane; Haack, Tobias B.; Keren, Boris; Livshits, Ludmilla A.; Mei, Davide; Park, Joohyun; Pisano, Tiziana; Prouteau, Clement; Umair, Muhammad; Waqas, Ahmed; Ziegler, Alban; Guerrini, Renzo; Møller, Rikke S.; Tümer, Zeynep.

I: Clinical Genetics, Bind 100, Nr. 5, 2021, s. 628-633.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Nøstvik, M, Kateta, SM, Schönewolf-Greulich, B, Afenjar, A, Barth, M, Boschann, F, Doummar, D, Haack, TB, Keren, B, Livshits, LA, Mei, D, Park, J, Pisano, T, Prouteau, C, Umair, M, Waqas, A, Ziegler, A, Guerrini, R, Møller, RS & Tümer, Z 2021, 'Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders', Clinical Genetics, bind 100, nr. 5, s. 628-633. https://doi.org/10.1111/cge.14051

APA

Nøstvik, M., Kateta, S. M., Schönewolf-Greulich, B., Afenjar, A., Barth, M., Boschann, F., Doummar, D., Haack, T. B., Keren, B., Livshits, L. A., Mei, D., Park, J., Pisano, T., Prouteau, C., Umair, M., Waqas, A., Ziegler, A., Guerrini, R., Møller, R. S., & Tümer, Z. (2021). Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. Clinical Genetics, 100(5), 628-633. https://doi.org/10.1111/cge.14051

Vancouver

Nøstvik M, Kateta SM, Schönewolf-Greulich B, Afenjar A, Barth M, Boschann F o.a. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. Clinical Genetics. 2021;100(5):628-633. https://doi.org/10.1111/cge.14051

Author

Nøstvik, Miriam ; Kateta, Sarah M. ; Schönewolf-Greulich, Bitten ; Afenjar, Alexandra ; Barth, Magalie ; Boschann, Felix ; Doummar, Diane ; Haack, Tobias B. ; Keren, Boris ; Livshits, Ludmilla A. ; Mei, Davide ; Park, Joohyun ; Pisano, Tiziana ; Prouteau, Clement ; Umair, Muhammad ; Waqas, Ahmed ; Ziegler, Alban ; Guerrini, Renzo ; Møller, Rikke S. ; Tümer, Zeynep. / Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. I: Clinical Genetics. 2021 ; Bind 100, Nr. 5. s. 628-633.

Bibtex

@article{a1995cdba9484dc989a0974c57aa8680,

title = "Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders",

abstract = "Biallelic variants in PUS3 have recently been recognized as a rare cause of neurodevelopmental disorders. Pseudouridine synthase-3 encoded by PUS3 is an enzyme important for modification of various RNAs, including transfer RNA (tRNA). Here we present the clinical and genetic features of 21 individuals with biallelic PUS3 variants: seven new and 14 previously reported individuals, where clinical features of two were updated. The clinical and genetic information were collected through collaborations or by literature search. All individuals were characterized by the local clinicians and the gene variants were identified by next generation sequencing (NGS) based methodologies. The clinical picture was dominated by global developmental delay, epilepsy, hypotonia and microcephaly. Gray sclera, which has previously been suggested to be a characteristic feature of PUS3-associated phenotypes, was reported in only seven individuals. The patients had some dysmorphic facial features, but a recognizable gestalt was not observed. In conclusion, homozygous and compound heterozygous PUS3 variants lead to a rare neurodevelopmental disorder. Further functional studies are necessary to understand involvement of PUS3 and tRNA biogenesis in normal and abnormal brain development.",

keywords = "epilepsy, global developmental delay, intellectual disability, microcephaly, pseudouridine, PUS3, tRNA biogenesis, tRNA modification",

author = "Miriam N{\o}stvik and Kateta, {Sarah M.} and Bitten Sch{\"o}newolf-Greulich and Alexandra Afenjar and Magalie Barth and Felix Boschann and Diane Doummar and Haack, {Tobias B.} and Boris Keren and Livshits, {Ludmilla A.} and Davide Mei and Joohyun Park and Tiziana Pisano and Clement Prouteau and Muhammad Umair and Ahmed Waqas and Alban Ziegler and Renzo Guerrini and M{\o}ller, {Rikke S.} and Zeynep T{\"u}mer",

note = "Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd",

year = "2021",

doi = "10.1111/cge.14051",

language = "English",

volume = "100",

pages = "628--633",

journal = "Clinical Genetics",

issn = "0009-9163",

publisher = "Wiley-Blackwell",

number = "5",

}

RIS

TY - JOUR

T1 - Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders

AU - Nøstvik, Miriam

AU - Kateta, Sarah M.

AU - Schönewolf-Greulich, Bitten

AU - Afenjar, Alexandra

AU - Barth, Magalie

AU - Boschann, Felix

AU - Doummar, Diane

AU - Haack, Tobias B.

AU - Keren, Boris

AU - Livshits, Ludmilla A.

AU - Mei, Davide

AU - Park, Joohyun

AU - Pisano, Tiziana

AU - Prouteau, Clement

AU - Umair, Muhammad

AU - Waqas, Ahmed

AU - Ziegler, Alban

AU - Guerrini, Renzo

AU - Møller, Rikke S.

AU - Tümer, Zeynep

PY - 2021

Y1 - 2021

N2 - Biallelic variants in PUS3 have recently been recognized as a rare cause of neurodevelopmental disorders. Pseudouridine synthase-3 encoded by PUS3 is an enzyme important for modification of various RNAs, including transfer RNA (tRNA). Here we present the clinical and genetic features of 21 individuals with biallelic PUS3 variants: seven new and 14 previously reported individuals, where clinical features of two were updated. The clinical and genetic information were collected through collaborations or by literature search. All individuals were characterized by the local clinicians and the gene variants were identified by next generation sequencing (NGS) based methodologies. The clinical picture was dominated by global developmental delay, epilepsy, hypotonia and microcephaly. Gray sclera, which has previously been suggested to be a characteristic feature of PUS3-associated phenotypes, was reported in only seven individuals. The patients had some dysmorphic facial features, but a recognizable gestalt was not observed. In conclusion, homozygous and compound heterozygous PUS3 variants lead to a rare neurodevelopmental disorder. Further functional studies are necessary to understand involvement of PUS3 and tRNA biogenesis in normal and abnormal brain development.

AB - Biallelic variants in PUS3 have recently been recognized as a rare cause of neurodevelopmental disorders. Pseudouridine synthase-3 encoded by PUS3 is an enzyme important for modification of various RNAs, including transfer RNA (tRNA). Here we present the clinical and genetic features of 21 individuals with biallelic PUS3 variants: seven new and 14 previously reported individuals, where clinical features of two were updated. The clinical and genetic information were collected through collaborations or by literature search. All individuals were characterized by the local clinicians and the gene variants were identified by next generation sequencing (NGS) based methodologies. The clinical picture was dominated by global developmental delay, epilepsy, hypotonia and microcephaly. Gray sclera, which has previously been suggested to be a characteristic feature of PUS3-associated phenotypes, was reported in only seven individuals. The patients had some dysmorphic facial features, but a recognizable gestalt was not observed. In conclusion, homozygous and compound heterozygous PUS3 variants lead to a rare neurodevelopmental disorder. Further functional studies are necessary to understand involvement of PUS3 and tRNA biogenesis in normal and abnormal brain development.

KW - epilepsy

KW - global developmental delay

KW - intellectual disability

KW - microcephaly

KW - pseudouridine

KW - PUS3

KW - tRNA biogenesis

KW - tRNA modification

U2 - 10.1111/cge.14051

DO - 10.1111/cge.14051

M3 - Journal article

C2 - 34415064

AN - SCOPUS:85113969890

VL - 100

SP - 628

EP - 633

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 5

ER -

ID: 279274997